The Eczema Association of Australasia Inc (EAA) is very excited to offer a new grant opportunity for Australasian College of Dermatologists (ACD) Fellows and trainees to undertake research into eczema and atopic dermatitis.
This new grant aims to help better understand and address the needs of patients and the ACD is delighted to administer this new grant on behalf of the EAA.
By donating the money for this funding grant the EAA’s hope for the future is that there will be better outcomes for eczema patients.
Applications will be accepted from 1 August up until 31 August 2021.
For eligibility, terms and conditions, and to apply, please visit the ACD website:
The Eczema Association of Australasia Inc (EAA) has been collecting responses for its Eczema Sufferer Survey for over 25 years. The survey is conducted in pen and paper format and responses have been sourced through a variety of methods. In total 4,039 responses were collected between 1994 and 2019.
Eczema is most commonly diagnosed at or soon after birth; 53% of surveys indicated that the condition was diagnosed between the ages of 0 - 6 months. A further 11% were diagnosed before their first birthday, meaning just under two-thirds of all eczema suffers are diagnosed between birth and 1 year of age.
A little over half current sufferers said that eczema moderately affect their daily life. With only 19% claiming to have no affect.
Just over half of eczema sufferers (52%) must also be conscious of environmental and physical triggers that worsen their condition. Of those whose condition is triggered, the weather is the biggest issue for them (72% of those whose condition is triggered). After weather, the biggest triggers for many are stress (57% of respondents mentioned), food (51%), soap (48%) and grass (36%). It is clear by the fact that many respondents chose multiple triggers, that for each individual there are a number of things to be conscious of and avoid.
A little over half of current sufferers describe their Eczema condition as Chronic. With just 6% claiming their condition is Controllable.
It is an exciting time in dermatology. After a long drought of new therapies for eczema, many new treatments are now on the horizon, made possible by new and better understandings of disease mechanisms in eczema. These new medications target specific molecules found to contribute to eczema.
Moving between the cold outdoors and an overheated and dry home can aggravate eczema symptoms. With eczema the skin barrier isn’t working as it should. As well as protecting from allergens and irritations, the skin barrier is an important part of controlling the body temperature.
The human skin is the largest organ in the body, measuring 1.8 square metres, but the impact of skin conditions on mental health cuts much deeper. While skin is responsible for everything from experiencing touch, to detecting heat and cold and protecting from infection.
Millions of people worldwide suffer from hand eczema. Researchers therefore investigate how to ease the burden of this condition, but they need the assistance of patients to make sure that their findings are indeed helpful.
From 1 March, a first-in-class biologic therapy known as Dupixent® (dupilumab) will be listed on the Pharmaceutical Benefits Scheme for the treatment of patients 12 years or older with severe atopic dermatitis, who have failed to respond to optimally prescribed topical treatments.
Baby wipes have been shown to be safe and effective in maintaining skin integrity when compared to the use of water alone. However, no previous study has compared different formulations of wipe.
Eczema is a common skin condition in infants, affecting up to 20% of babies worldwide. The most common type of eczema that affects children is atopic dermatitis, appearing as rashes on the cheeks, chest, and head.
Nothing is more satisfying than scratching an intense itch. Likewise, nothing is more frustrating than a persistent itch that evades relief. Psoriasis and eczema are two relatively common skin disorders that cause dryness, itching, and rashes.
Dupilumab* (Dupixent®) is a new ‘biologic’ treatment for severe eczema which works in a different way to the other drugs that are currently available for eczema. Biologic drugs are produced by genetically modified organisms such as bacteria.
This publication from Professor Irwin McLean’s group, shows that lack of the protein filaggrin in the skin caused an inherited dry skin condition known as ichthyosis vulgaris that is strongly linked to the development of atopic eczema. More studies have confirmed this finding and at least 20 loss-of-function mutations (changes in a gene that prevent it working properly) causing filaggrin deficiency have been discovered in many different racial groups. Filaggrin deficiency has also been linked to more severe atopic eczema and to its persistence into adult life.Read More
Eczema is a chronic condition. That means it is not curable and has to be controlled. It is a condition where the skin is constantly inflamed. For over 50 years, topical steroids have been known to be highly effective in controlling this inflammation. There is no other medication that works as well or as efficiently. One of the main functions of skin is to maintain a barrier to the outside world. In eczema the barrier is damaged. Steroids rapidly repair the damaged skin barrier without irritating the skin.Read More
Although many people think an emollient and a moisturiser are the same thing, they aren’t. An emollient is one of the ingredients in a moisturiser. The other ingredients in a moisturiser bring water into your skin. Emollients are the part of a moisturiser that keep your skin soft and smooth. Emollients have been used for over 5,000 years and they form an essential part of the therapy for all dry skin conditions, including atopic and contact eczema. Emollients are safe and effective and, in the majority of cases, mild to moderate eczema can be successfully treated by using emollient therapy alone.Read More
One in eight children have eczema at one time or another as do one in twelve adults. Some of the latter are adults whose eczema has lingered on, while others will have eczema for the first time in adulthood. Some people will have had eczema for the first time as babies or young children and then experience several years of remission only to have the eczema re-appear suddenly and sometimes severely in their adult years. Since one of the homilies that seems to have attached itself to the condition is “you will grow out of it”, it is small wonder that adults with eczema become quite desperate.Read More
The teenage years can sometimes be the worst for people with eczema. This is not because the condition gets worse at this time: it can get better. As the skin gets greasier the eczema often improves and it is not uncommon for someone who has had eczema severely as a child to become much better at puberty while his non-eczematous friend discovers zits in a big way!
On the other hand, some people find that they have been free of eczema for a while only for it to come back in adolescence: others develop the condition for the first time during the teenage years. It is a very individual condition.Read More
There are different skin disorders, some of which can start very early on in life, such as cradle cap. This thick scurfy scalp can appear soon after birth or when the baby is a few months old. It can develop suddenly. The scalp becomes coated with greasy yellow scales that stick to the head giving a crusty appearance. This scaliness can affect other parts of the baby’s face and head including the forehead, temples, eyebrows, behind the ears and in the neck folds. The skin underneath the scales may look sore, but it is not a condition that causes discomfort or itching.Read More
An explanation of the relationship between infection and eczema including causes and treatment. Skin affected by eczema tends to develop small cracks and fissures on the surface. This provides entry points for bacteria, which cause infection. Infection makes eczema worse and treatment more difficult. The skin can become more cracked which leads the way to further infection. Breaking this cycle of infection is the key to successful treatment. Both contact and atopic eczema may become infected in this way.Read More
Ear eczema can be an extremely irritating and, at times, painful condition. It can range from slight dryness of the pinna (the visible, projecting part of the ear) to extensive skin loss and soreness, as well as infection of the external and internal parts of the ear.
Eczema can affect the entire ear including the ear lobes, conchal bowl (the area outside the ear-hole), the ear opening (meatus), ear canal (also known as the external auditory canal – the part of the ear which leads to the ear drum) and the ear drum itself (also known as the tympanic membrane).Read More
Why do it? Many people carry bacteria called Staphylococcus aureus on their skin. This is particularly common in children and adults who suffer from eczema.
Eczema is an itchy skin condition, often worsened by a bacterial infection. Staphylococcus aureus can contribute to the flaring of the eczema and to ongoing skin inflammation. Complete eradication of Staphylococcus aureus in patients with eczema is very difficult, however some therapies can reduce the number of organisms which live on the skin.Read More
I joined the Eczema Association of Australasia last year, after becoming desperate for an end to my itchy, red skin. I was first diagnosed with eczema around the age of 20 and prescribed a mild steroid cream for the rash on my chest. The rash cleared and the unfinished tube of cream sat idle in my bathroom cupboard for years. In my late twenties and thirties, I occasionally developed a small patch of dry skin, which I sometimes treated with a topical steroid cream or with a non‐steroidal emollient. It wasn’t until my early forties that my skin rash become problematic.Read More